header
Image from OpenLibrary

Comparative prospective study of temozolomide as a radiosensitizer by different protocols in glioblastoma multiform / Dina Ezz Eldin Faheem ; Supervised May Hussein Gaber , Hanan Seleem , Tamer Elnahas

By: Contributor(s): Material type: TextTextLanguage: English Publication details: Cairo : Dina Ezz Eldin Faheem , 2013Description: 129 P. : charts , facsimiles ; 25cmOther title:
  • دراسة مقارنة مستقبلية لعقار التيموزولامايد كمحفز للعلاج الإشعاعى من خلال نظم مختلفة فى أورام المخ الخبيثة متعددة الأشكال [Added title page title]
Subject(s): Available additional physical forms:
  • Issued also as CD
Dissertation note: Thesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Oncology-Clinical Summary: Glioblastoma multiforme is one of the most aggressive brain tumors, which should be maximally resescted as much as possible to obtain further and better outcome. The standard adjuvant treatment at present is radiation therapy concomitant, with temodal which approved in multiple phase {u2162} trials which demonstrated significant improvement in the outcome and survival of patients
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Home library Call number Copy number Status Date due Barcode
Thesis Thesis قاعة الرسائل الجامعية - الدور الاول المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.11.23.Ph.D.2013.Di.C (Browse shelf(Opens below)) Not for loan 01010110062231000
CD - Rom CD - Rom مخـــزن الرســائل الجـــامعية - البدروم المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.11.23.Ph.D.2013.Di.C (Browse shelf(Opens below)) 62231.CD Not for loan 01020110062231000

Thesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Oncology-Clinical

Glioblastoma multiforme is one of the most aggressive brain tumors, which should be maximally resescted as much as possible to obtain further and better outcome. The standard adjuvant treatment at present is radiation therapy concomitant, with temodal which approved in multiple phase {u2162} trials which demonstrated significant improvement in the outcome and survival of patients

Issued also as CD

There are no comments on this title.

to post a comment.